CAV1 and cancer: Using multiple experimental approaches, we define a mechanism through which Cav-1 alters mitochondrial dynamics in addition to promoting cancer cell lipid uptake and altering ceramide metabolism that results in increased glycosphingolipid synthesis and efflux of sphingolipid-enriched EVs that contain mitochondrial proteins.